Histone Deacetylase Inhibitors Synergizes With Catalytic Inhibitors of EZH2 to Exhibit Anti-Tumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0348
Full Text
Open PDFAbstract
Available in full text
Date
September 19, 2018
Authors
Publisher
American Association for Cancer Research (AACR)